Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are male
- You are between 2 and 24 years old at the time of joining the trial
- You have been diagnosed with a dystrophinopathy (a muscle disease related to the DMD gene) that has been confirmed through genetic testing
- Your genetic diagnosis was made using at least one recognised testing method, such as MLPA, next-generation sequencing, Sanger sequencing, array-CGH, or qPCR (confirm with trial site if unsure which test you had)
- A parent or legal guardian has given written consent for participation, and the participant themselves has also given consent where appropriate
Who may not be able to join:
- Your diagnosis has not been confirmed by genetic testing — for example, if it was based only on a muscle biopsy without a confirmed change in the DMD gene
- Your mother has been identified as a carrier of a DMD gene change, but your own genetic test has not confirmed you personally carry a disease-causing variant (unless repeat testing confirms this in you)
- You have a heart condition you were born with, or another genetic condition that directly affects the heart muscle
- You have another neuromuscular disorder (a condition affecting the muscles or the nerves that control them)
- You are a female carrier of the DMD gene change, whether or not you have symptoms
- You have another health condition that may affect how your heart works, such as severely high blood pressure, diabetes, or chronic kidney disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andreas Giannopoulos, Professor of Pediatrics and Pediatric Cardiology, MD, PhD, Aristotle University Of Thessaloniki
Phone: +30 2313303534
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between pathogenic DMD gene variants and left ventricular ejection fraction (EF); Correlation between pathogenic DMD gene variants and global longitudinal strain (GLS); Correlation between pathogenic DMD gene variants and blood levels of high-sensitivity troponin T (hs-TnT); Correlation between pathogenic DMD gene variants and blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.